Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-0.77%
End price
10.07.26
€64.50
Summary
This prediction ended on 10.07.26 with a price of €64.50. The BUY prediction by Citigroup_Inc_ for Haemonetics Corp. closed nearly unchanged. Citigroup_Inc_ has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | 16.981% | 16.981% | - |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€41.40
07.10.25
07.10.25
€54.71
07.10.26
07.10.26
119.81%
20.08.26
20.08.26
